Browsing Tag
Wilson Wolf Corporation
1 post
Why Merck KGaA is spending $11.3bn on Bio-Techne instead of another drug pipeline
Merck KGaA plans to acquire Bio-Techne for $11.3 billion. Read why laboratory tools, recurring revenue and debt-funded growth could reshape its strategy.